At the time of writing, Edwards Lifesciences Corp [EW] stock is trading at $76.31, down -1.88%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EW shares have gain 2.21% over the last week, with a monthly amount drifted -6.68%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on July 29, 2025, when BTIG Research upgraded its rating to a Buy but kept the price target unchanged to $100 for it. Previously, Piper Sandler upgraded its rating to Overweight on April 24, 2025, and kept the price target unchanged to $80. On January 30, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $90 on the stock. Wolfe Research downgraded its rating to a Underperform but stick to its price target of $60 on January 16, 2025. BofA Securities upgraded its rating to a Buy. In a note dated September 18, 2024, Jefferies downgraded an Hold rating on this stock and revised its target price from $85 to $70.
For the past year, the stock price of Edwards Lifesciences Corp fluctuated between $64.00 and $83.00. Currently, Wall Street analysts expect the stock to reach $80 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $76.31 at the most recent close of the market. An investor can expect a potential return of 4.84% based on the average EW price forecast.
Analyzing the EW fundamentals
According to Edwards Lifesciences Corp [NYSE:EW], the company’s sales were 5.69B for trailing twelve months, which represents an 10.56% jump. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.73%. To continue investigating profitability, this company’s Return on Assets is posted at 0.31, Equity is 0.41 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.02 points at the first support level, and at 71.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 78.49, and for the 2nd resistance point, it is at 80.66.
Ratios To Look Out For
It is important to note that Edwards Lifesciences Corp [NYSE:EW] has a current ratio of 4.68. Also, the Quick Ratio is 3.87, while the Cash Ratio stands at 2.33. Considering the valuation of this stock, the price to sales ratio is 7.88, the price to book ratio is 4.25 and price to earnings (TTM) ratio is 52.10.
Transactions by insiders
Recent insider trading involved Chopra Daveen, CVP, TMTT, that happened on Aug 25 ’25 when 2500.0 shares were sold. Officer, Chopra Daveen completed a deal on Aug 25 ’25 to buy 2500.0 shares. Meanwhile, Global President TAVR & Surg Wood Larry L sold 8950.0 shares on Aug 18 ’25.
